Literature DB >> 14557886

Differential binding of platelet-derived growth factor isoforms to glycosaminoglycans.

Raquel García-Olivas1, Johan Hoebeke, Susanna Castel, Manuel Reina, Gunnar Fager, Florentina Lustig, Senén Vilaró.   

Abstract

The platelet-derived growth factor (PDGF) family comprises disulfide-bonded dimeric isoforms and plays a key role in the proliferation and migration of mesenchymal cells. Traditionally, it consists of homo- and heterodimers of A and B polypeptide chains that occur as long (A(L) and B(L)) or short (A(S) and B(S)) isoforms. Short isoforms lack the basic C-terminal extension that mediates binding to heparin. In the present study, we show that certain PDGF isoforms bind in a specific manner to glycosaminoglycans (GAGs). Experiments performed with wild-type and mutant Chinese hamster ovary cells deficient in the synthesis of GAGs revealed that PDGF long isoforms bind to heparan sulfate and chondroitin sulfate, while PDGF short isoforms only bind to heparan sulfate. This was confirmed by digestion of cell surface GAGs with heparitinase and chondroitinase ABC and by incubation with sodium chloride to prevent GAG sulfation. Furthermore, exogenous GAGs inhibited the binding of long isoforms to the cell membrane more efficiently than that of short isoforms. Additionally, we performed surface plasmon resonance experiments to study the inhibition of PDGF isoforms binding to low molecular weight heparin by GAGs. These experiments showed that PDGF-AA(L) and PDGF-BB(S) isoforms bound to GAGs with the highest affinity. In conclusion, PDGF activity at the cell surface may depend on the expression of various cellular GAG species.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557886     DOI: 10.1007/s00418-003-0576-6

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  51 in total

1.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation.

Authors:  A C Rapraeger; A Krufka; B B Olwin
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

2.  Binding and intracellular trafficking of lipoprotein lipase and triacylglycerol-rich lipoproteins by liver cells.

Authors:  R P Casaroli-Marano; R García; E Vilella; G Olivecrona; M Reina; S Vilaró
Journal:  J Lipid Res       Date:  1998-04       Impact factor: 5.922

3.  High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan.

Authors:  L Goretzki; M A Burg; K A Grako; W B Stallcup
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

4.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.

Authors:  A Hildebrand; M Romarís; L M Rasmussen; D Heinegård; D R Twardzik; W A Border; E Ruoslahti
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

5.  In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty.

Authors:  M Ueda; A E Becker; N Kasayuki; A Kojima; Y Morita; S Tanaka
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

6.  Heparan sulfate proteoglycans are primarily responsible for the maintenance of enzyme activity, binding, and degradation of lipoprotein lipase in Chinese hamster ovary cells.

Authors:  D E Berryman; A Bensadoun
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

7.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Authors:  A Yayon; M Klagsbrun; J D Esko; P Leder; D M Ornitz
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

8.  The antiproliferative activity of arterial heparan sulfate resides in domains enriched with 2-O-sulfated uronic acid residues.

Authors:  A Schmidt; K Yoshida; E Buddecke
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

9.  Loop III region of platelet-derived growth factor (PDGF) B-chain mediates binding to PDGF receptors and heparin.

Authors:  D Schilling; J D Reid IV; A Hujer; D Morgan; E Demoll; P Bummer; R A Fenstermaker; D M Kaetzel
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

10.  Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group.

Authors:  J J Castellot; J Choay; J C Lormeau; M Petitou; E Sache; M J Karnovsky
Journal:  J Cell Biol       Date:  1986-05       Impact factor: 10.539

View more
  11 in total

Review 1.  Innovative techniques and applications in histochemistry and cell biology.

Authors:  Esther Asan
Journal:  Histochem Cell Biol       Date:  2003-11-28       Impact factor: 4.304

Review 2.  Dynamic reciprocity in the wound microenvironment.

Authors:  Gregory S Schultz; Jeffrey M Davidson; Robert S Kirsner; Paul Bornstein; Ira M Herman
Journal:  Wound Repair Regen       Date:  2011 Mar-Apr       Impact factor: 3.617

Review 3.  Corneal myofibroblast biology and pathobiology: generation, persistence, and transparency.

Authors:  Steven E Wilson
Journal:  Exp Eye Res       Date:  2012-04-20       Impact factor: 3.467

Review 4.  Stem cell paracrine actions and tissue regeneration.

Authors:  Priya R Baraniak; Todd C McDevitt
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

Review 5.  Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling.

Authors:  Khushboo Gulati; Krishna Mohan Poluri
Journal:  Glycoconj J       Date:  2015-12-03       Impact factor: 2.916

6.  A novel mechanism of sequestering fibroblast growth factor 2 by glypican in lipid rafts, allowing skeletal muscle differentiation.

Authors:  Jaime Gutiérrez; Enrique Brandan
Journal:  Mol Cell Biol       Date:  2010-01-25       Impact factor: 4.272

7.  Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.

Authors:  Marco Rusnati; Antonella Bugatti; Stefania Mitola; Daria Leali; Paolo Bergese; Laura E Depero; Marco Presta
Journal:  Sensors (Basel)       Date:  2009-08-20       Impact factor: 3.576

8.  Murine neural stem cells model Hunter disease in vitro: glial cell-mediated neurodegeneration as a possible mechanism involved.

Authors:  E Fusar Poli; C Zalfa; F D'Avanzo; R Tomanin; L Carlessi; M Bossi; L Rota Nodari; E Binda; P Marmiroli; M Scarpa; D Delia; A L Vescovi; L De Filippis
Journal:  Cell Death Dis       Date:  2013-11-07       Impact factor: 8.469

9.  Serglycin in Quiescent and Proliferating Primary Endothelial Cells.

Authors:  Trine M Reine; Tram T Vuong; Arkady Rutkovskiy; Astri J Meen; Jarle Vaage; Trond G Jenssen; Svein O Kolset
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

Review 10.  Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.

Authors:  Paola Chiodelli; Antonella Bugatti; Chiara Urbinati; Marco Rusnati
Journal:  Molecules       Date:  2015-04-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.